The Pharma Letter21h
US FDA issues more warning letters to Asian producers
The US Food and Drug Administration (FDA) has issued several warning letters to pharmaceutical manufacturers in India and ...
Trump's China tariffs likely to drive up drug prices, spur shortages, experts say
President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...
FiercePharma17d
Sanofi API plant hit with FDA warning letter detailing quality, consistency flubs
which included “multiple microbiological contamination events,” the FDA noted. The French pharma also failed to show that its production process can reproducibly manufacture an API to certain ...
Aurobindo Pharma shares decline after U.S. FDA inspection report to subsidiary’s API plant
Aurobindo Pharma's shares drop over 3% after FDA inspection results in VAI classification for subsidiary's API plant.
Bajaj Healthcare bags major approval from DCGI to make API, formulation of antipsychotic drug Pimavanserin
Bajaj Health has also extended the offer for Pimavanserin to several leading pharma companies to ensure availability in ...
Global Drug Formulation Market to Hit USD 2.8 Trillion by 2035 Amidst Rising Demand for Advanced Oral Formulations | Future Market Insights, Inc.
The pharmaceutical industry has experienced a substantial revolution with the introduction of novel technologies as well as ...
Neurocrine Biosciences Q4 Earnings Preview: What To Expect After The New Drug Approval
Neurocrine's pipeline includes 12 clinical programs, with two Phase 3 trials due to report in 2025. See why I rate NBIX stock ...
tbsnews4d
Tax breaks, cash incentives, low-cost loans on the table for API investors
If implemented, this initiative could be a game-changer. Industry insiders estimate that Bangladesh could save $1 billion in foreign currency annually by reducing its reliance on imported APIs ...